20120114
 Picks for New Contest   By Ensign, Rachel Louise, The Wall Street Journal,  Jan 15, 2012  Amgen (AMGN, $64.21): An aging population and increased use of prescription drugs mean a sunny future for this drug maker, says Loel Fordham of Port St. Lucie, Fla., who reads Scripps Treasure Coast Newspapers.   
